Trials / Completed
CompletedNCT06103994
Study to Assess the Effect of Multistrain Probiotic on the Immune Response to the Influenza Vaccination
A Randomized, Triple-blinded, Placebo-controlled, Parallel Group Study, to Assess the Effect of Multistrain Probiotic on the Immune Response to the Influenza Vaccination
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 120 (actual)
- Sponsor
- The Archer-Daniels-Midland Company · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
A randomized, triple-blinded, placebo-controlled, parallel group study, to assess the effect of multistrain probiotic on the immune response to the Influenza vaccination
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Multistrain probiotic | Multistrain Probiotic |
| OTHER | Placebo | Placebo |
Timeline
- Start date
- 2023-10-27
- Primary completion
- 2024-01-12
- Completion
- 2024-01-12
- First posted
- 2023-10-27
- Last updated
- 2025-04-10
Locations
1 site across 1 country: Greece
Source: ClinicalTrials.gov record NCT06103994. Inclusion in this directory is not an endorsement.